All News #Library
Others
Nutcracker: Enhanced B-Cell Lymphoma Candidate At ASCO 2024
05 Jun 2024 //
BUSINESSWIRE
Nutcracker To Unveil NTX-472, Present At ASCO, Sachs Forum
16 May 2024 //
BUSINESSWIRE
Nutcracker Named Industry Veteran Samuel Deutsch as Chief Scientific Officer
08 Jan 2024 //
BUSINESSWIRE
Nutcracker lays off a dozen staffers after $167M round in 2022
21 Jun 2023 //
FIERCE BIOTECH
Nutcracker appoints Cynthia Collins, biopharma veteran former Editas Med CEO
09 May 2023 //
BUSINESSWIRE
Nutcracker Appoints Veteran Angela Peters as Chief Human Resources Officer
07 Mar 2023 //
BUSINESSWIRE
Nutcracker Therapeutics Adds Dr. Thomas J. Dietz to Board of Directors
06 Feb 2023 //
BUSINESSWIRE
Nutcracker Reports Strong Anti-Tumor Responses of Lead mRNA Immunotherapy
11 Nov 2022 //
BUSINESSWIRE
Nutcracker Therapeutics Bolsters Leadership with CPO
22 Jun 2022 //
BUSINESSWIRE
GMP-in-a-box company lands $167M to develop its own cancer drugs
15 Mar 2022 //
ENDPTS

Market Place
Sourcing Support